Sinuva (Mometasone Furoate) & Cataracts, Diminished Visual Acuity, Glaucoma, and Nasal Septal Perforation

Basic Details
Status
Ongoing
Last Updated
Monday, December 18, 2017
Health Outcome(s)
cataracts
diminished visual acuity
glaucoma
nasal septal perforation
Purpose
Drug and Outcome Analysis
Regulatory Determination / Use

Feasibility assessment of ARIA sufficiency to replace a sponsor postmarketing requirement (PMR) safety study for Sinuva (mometasone furoate)